Global X Management Company’s Edwards Lifesciences EW Stock Holding History

Global X Management Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.65M	Buy	33,981 +4,026	+13%	+$188K	0.03%	349
2018 Q1	$1.39M	Buy	29,955 +3,528	+13%	+$153K	0.03%	340
2017 Q4	$993K	Buy	26,427 +14,979	+131%	+$550K	0.02%	371
2017 Q3	$417K	Buy	11,448 +933	+9%	+$35.6K	0.01%	584
2017 Q2	$414K	Sell	10,515 -657	-6%	-$24K	0.01%	565
2017 Q1	$350K	Buy	11,172 +2,403	+27%	+$75.2K	0.01%	574
2016 Q4	$274K	Buy	8,769 +2,559	+41%	+$82.9K	0.01%	549
2016 Q3	$250K	Buy	6,210 +3,528	+132%	+$133K	0.01%	524
2016 Q2	$89K	Buy	2,682 +822	+44%	+$28.1K	﹤0.01%	557
2016 Q1	$55K	Buy	1,860 +1,656	+812%	+$45.7K	﹤0.01%	520
2015 Q4	$5K	Sell	204 -12	-6%	-$312	﹤0.01%	669
2015 Q3	$5K	Hold	216	–	–	﹤0.01%	749
2015 Q2	$5K	Buy	+216	New	+$4.88K	﹤0.01%	718

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Global X Management Company's EW Position: Q2 2018 in Review

Global X Management Company increased its Edwards Lifesciences (EW) stake by 13% in Q2 2018, buying an estimated $188K and bringing the position to 33,981 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #349.

Global X Management Company first reported a position in EW in Q2 2015 and has held it in 13 quarters since. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

Global X Management Company held 33,981 shares of Edwards Lifesciences worth $1.65M as of Q2 2018.
Global X Management Company bought 4,026 Edwards Lifesciences shares in Q2 2018, an estimated $188K.
Edwards Lifesciences made up 0.03% of Global X Management Company's portfolio in Q2 2018, its #349 holding.
Global X Management Company first reported a position in Edwards Lifesciences in Q2 2015 and has held it in 13 quarters since.
838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.